Science Friday

Body Temperature, COVID Vaccines, Dog Genomics. Nov 13, 2020, Part 2

11.13.2020 - By Science Friday and WNYC StudiosPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Our Average Body Temperature Is Getting Cooler

We’ve all been getting our temperature checked on the regular these days. Most restaurants and businesses have been scanning peoples’ foreheads with thermometer guns to check for signs of fever as a safety precaution for COVID-19. We’ve been told that our temperature should be around 98.6 degrees Fahrenheit (or 37 degrees Celsius), the “normal” human body temperature. The value was set over 150 years ago by the German physician Carl Reinhold August Wunderlich. But 98.6 degrees may no longer be the golden standard. 

In several studies, researchers have found that the average human body temperature may be lowering. Producer Alexa Lim talks with infectious disease specialist Julie Parsonnet about what temperature can tell us about our body and overall human health. 

Fact Check My Feed: How Excited Should You Be About COVID-19 Vaccines?

As COVID-19 cases and hospitalizations set new records, worse than even the initial surge this spring, there was one piece of promising pandemic news this week: a press release from the pharmaceutical company Pfizer, one of several racing toward developing a vaccine.

Pfizer, working with German company BioNTech, announced Monday that their vaccine candidate, which uses a new technology involving mRNA, had reached an efficacy of 90 percent based on interim data. Trial participants were either given the vaccine or a placebo. Enough of the participants in the placebo group have since gone on to get COVID-19 to offer clues to its success: These rates suggest that nine out of 10 people who receive the vaccine will be protected from symptoms of disease. 

But, as many have pointed out, Pfizer’s optimistic claims did not come with any release of data to back them up—nor an understanding of whether the most vulnerable would receive the same level of protection. Furthermore, this is only an interim analysis, meaning there’s more the company still has to learn before settling on a final efficacy number. 

There are many questions yet to answer: For example, the process of understanding a vaccine’s safety takes much longer, and more people, than any trial period can fully assess. And even if Pfizer’s vaccine is approved by the U.S. Food and Drug Administration, how will a vaccine that requires two doses and expensive deep-freeze storage be distributed to all the people who need it? 

Other vaccine candidates are also moving quickly. Another mRNA vaccine maker, Moderna, also indicated this week by press release that they will have their own interim analysis ready soon.

Ira fact—and reality—checks the latest news on COVID-19 vaccine trials with virologist Angela Rasmussen and biostatistician Natalie Dean.

How To Decode Your Dog’s DNA

While we have been sitting at home for months, some of you have been spending a lot more time with your pets. You might stare at your dog and wonder: What exactly is your breed? Well, some people have been taking the extra step in finding out more about their furry quarantine companion—by getting a dog DNA test.

Producer Katie Feather talks with pet genomics experts (yes, they exist!) about what you can and can’t learn from these direct-to-consumer genetics tests for dogs. They also discuss a citizen science project that studies connections between your pup’s genes and their behavior.

More episodes from Science Friday